// App-Quantinova.ai

354 : CD34+CD38-CD58- Candidate Leukemia-Initiating Cells Are Clinically Relevant With The Unfavorable Prognosis In Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Researchers

Presenter

  • Yuan Kong

Principal Investigators

  • Ying-Jun Chang

  • Yan-Rong Liu

  • Dai-hong Liu

  • Xiao-jun Huang

  • Ya-zhe Wang

  • Qian Jiang

  • Hao Jiang

  • Ya-Zhen Qin

  • Jing Wang

  • Hong-Hu Zhu

  • Yue-Yun Lai

  • Lanping Xu

Medical Centers

  • Peking University Peoples Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China

  • Peking University Peoples Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • Cluster of Differentiation 34

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved